U.S. Markets closed

Elan publishes response document regarding Echo Pharma offer

Elan announces publication of a response document in respect of the Echo Pharma Acquisition Limited offer made on May 2. The response document is published in accordance with Rules 25 and 30.3 of the Irish Takeover Rules and the United States tender offer rules. As previously advised, the Board of Elan has unanimously, and without reservation, rejected the offer by Royalty Pharma. Shareholders are strongly advised to take no action in relation to the offer.